Cell-free expression of functional receptor tyrosine kinases

被引：22

作者：

He, Wei ^{[1
]}

Scharadin, Tiffany M. ^{[2
]}

Saldana, Matthew ^{[3
]}

Gellner, Candice ^{[2
]}

Hoang-Phou, Steven ^{[1
]}

Takanishi, Christina ^{[2
]}

Hura, Gregory L. ^{[4
,5
]}

Tainer, John A. ^{[4
,6
]}

Carraway, Kermit L., III ^{[3
,7
]}

Henderson, Paul T. ^{[2
,7
]}

Coleman, Matthew A. ^{[1
,7
,8
]}

机构：

[1] Univ Calif Davis, Sch Med, Radiat Oncol, Sacramento, CA 95817 USA

[2] Univ Calif Davis, Sch Med, Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA

[3] Univ Calif Davis, Sch Med Biochem & Mol, Sacramento, CA 95817 USA

[4] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA

[5] Univ Calif Santa Cruz, Chem & Biochem, Santa Cruz, CA 95064 USA

[6] Scripps Res Inst, La Jolla, CA 92037 USA

[7] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA

[8] Lawrence Livermore Natl Lab, Livermore, CA USA

来源：

SCIENTIFIC REPORTS | 2015年 / 5卷

基金：

美国国家科学基金会;

关键词：

GROWTH-FACTOR RECEPTOR; X-RAY-SCATTERING; MEMBRANE-PROTEINS; ACTIVATION; ERBB2; SAXS;

D O I：

10.1038/srep12896

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Receptor tyrosine kinases (RTKs) play critical roles in physiological and pathological processes, and are important anticancer drug targets. In vitro mechanistic and drug discovery studies of full-length RTKs require protein that is both fully functional and free from contaminating proteins. Here we describe a rapid cell-free and detergent-free co-translation method for producing full-length and functional ERBB2 and EGFR receptor tyrosine kinases supported by water-soluble apolipoprotein A-I based nanolipoprotein particles.

引用

页数：8

共 50 条

[31] Receptor tyrosine kinases: from biology to pathology
Choura, Mouna
Rebai, Ahmed
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2011, 31 (06) : 387 - 394
[32] Eph Receptor Tyrosine Kinases in Tumor Immunity
Shiuan, Eileen
Chen, Jin
CANCER RESEARCH, 2016, 76 (22) : 6452 - 6457
[33] Receptor Tyrosine Kinases and Targeted Cancer Therapeutics
Takeuchi, Kenji
Ito, Fumiaki
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (12) : 1774 - 1780
[34] Role of Receptor Tyrosine Kinases and Their Ligands in Glioblastoma
Carrasco-Garcia, Estefania
Saceda, Miguel
Martinez-Lacaci, Isabel
CELLS, 2014, 3 (02) : 199 - 235
[35] Cell-free platforms for flexible expression and screening of enzymes
Catherine, Christy
Lee, Kyung-Ho
Oh, Su-Jin
Kim, Dong-Myung
BIOTECHNOLOGY ADVANCES, 2013, 31 (06) : 797 - 803
[36] Development and optimization of a coupled cell-free system for the synthesis of the transmembrane domain of the receptor tyrosine kinase ErbB3
N. F. Khabibullina
E. N. Lyukmanova
G. S. Kopeina
Z. O. Shenkarev
A. S. Arsen’ev
D. A. Dolgikh
M. P. Kirpichnikov
Russian Journal of Bioorganic Chemistry, 2010, 36 : 603 - 609
[37] Receptor tyrosine kinases with intracellular pseudokinase domains
Mendrola, Jeannine M.
Shi, Fumin
Park, Jin H.
Lemmon, Mark A.
BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 1029 - 1036
[38] Targeting receptor tyrosine kinases in gastric cancer
Morishita, Asahiro
Gong, Jian
Masaki, Tsutomu
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (16) : 4536 - 4545
[39] AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
Choi, Yun Jung
Kim, Ji Hye
Rho, Jin Kyung
Kim, Joong Sun
Choi, Chang-Min
Kim, Woo Sung
Son, Jaekyoung
Lee, Jae Cheol
ONCOLOGY REPORTS, 2017, 37 (04) : 2201 - 2208
[40] Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish
D'Agati, Gianluca
Cabello, Elena Maria
Frontzek, Karl
Rushing, Elisabeth J.
Klemm, Robin
Robinson, Mark D.
White, Richard M.
Mosimann, Christian
Burger, Alexa
DISEASE MODELS & MECHANISMS, 2019, 12 (07)

← 1 2 3 4 5 →